| Takeda Pharma AG - Pantozol i.v., Lyophilisat |
| 55551 | | 02 | | Pantozol i.v. | | Lyophilisat | | A02BC02 | | Pantoprazole | | 01.03.2005 | | |
|
| Composition |
| Praeparatio cryodesiccata: pantoprazolum 40 mg ut pantoprazolum natricum, dinatrii edetas, natrii hydroxidum, pro vitro corresp. natrium 2.68 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Pantoprazole | 40 mg |
| | BAG: Active Agent | Dose |
|---|
| Pantoprazole | 40 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | Durchstechflasche(n) | 2.79 | 12.25 | B | SL | Yes | | 012 | 360 1 Durchstechflasche(n) | 7.16 | 16.60 | B | | Yes | | 013 | 10 1 Durchstechflasche(n) | 22.32 | 40.70 | B | SL | Yes |
|
